Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2
Clinical trial NCT05554432 · UNKNOWN
Trial details
- NCT number
- NCT05554432
- Sponsor
- Institut Curie
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-12
- Primary completion
- 2025-04-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.